采用冷冻胶囊进行粪便微生物群移植治疗难治性急性肠道移植物抗宿主病。
Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease.
机构信息
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; and.
出版信息
Blood Adv. 2018 Nov 27;2(22):3097-3101. doi: 10.1182/bloodadvances.2018024968.
Abstract
Bacterial diversity was restored after FMT with oral frozen capsules, with improvement of diarrhea. Oral FMT for steroid-refractory acute gGVHD is feasible and could be effective.
摘要
粪便微生物移植（FMT）采用口服冷冻胶囊后，细菌多样性得到恢复，腹泻症状得到改善。口服 FMT 治疗类固醇难治性急性移植物抗宿主病是可行的，并且可能有效。
相似文献
1
Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease.采用冷冻胶囊进行粪便微生物群移植治疗难治性急性肠道移植物抗宿主病。
Blood Adv. 2018 Nov 27;2(22):3097-3101. doi: 10.1182/bloodadvances.2018024968.
2
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft--host-disease.反复进行粪便微生物群移植可减轻急性难治性胃肠道移植物抗宿主病中的腹泻，并导致粪便微生物群的持续变化。
Haematologica. 2017 May;102(5):e210-e213. doi: 10.3324/haematol.2016.154351. Epub 2017 Feb 2.
3
Rapid Resolution of Graft-versus-Host-Disease-Related Central Serous Chorioretinopathy.移植物抗宿主病相关的中心性浆液性脉络膜视网膜病变的快速消退
Semin Ophthalmol. 2015;30(5-6):432-4. doi: 10.3109/08820538.2013.874473. Epub 2014 Feb 7.
4
Stool smears for diagnosis of intestinal acute graft-versus-host disease.用于诊断肠道急性移植物抗宿主病的粪便涂片。
Bone Marrow Transplant. 1999 Oct;24(7):799-801. doi: 10.1038/sj.bmt.1701958.
5
Blaschkoid Acute Graft-vs-Host Disease.线状急性移植物抗宿主病
JAMA Dermatol. 2018 Apr 1;154(4):494-495. doi: 10.1001/jamadermatol.2017.6023.
6
Atypical acute graft-versus-host disease.非典型急性移植物抗宿主病
Am J Dermatopathol. 2007 Dec;29(6):576-7. doi: 10.1097/DAD.0b013e3181594f6d.
7
Successful response to infliximab of recurrent pericardial graft versus host disease in a pediatric patient.一名儿科患者复发性心包移植物抗宿主病对英夫利昔单抗治疗的成功反应。
Bone Marrow Transplant. 2013 Jan;48(1):144-5. doi: 10.1038/bmt.2012.91. Epub 2012 May 14.
8
Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.粪菌移植治疗激素耐药性肠道急性移植物抗宿主病：一项初步研究。
Front Immunol. 2018 Sep 25;9:2195. doi: 10.3389/fimmu.2018.02195. eCollection 2018.
9
10
My Patient, the Superhero.我的病人，超级英雄。
J Clin Oncol. 2017 Apr 20;35(12):1368-1369. doi: 10.1200/JCO.2016.69.6005. Epub 2017 Feb 6.
引用本文的文献
1
Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study.异基因造血细胞移植后粪便微生物群移植治疗难治性慢性移植物抗宿主病：一项开放性、非安慰剂对照的初步研究。
BMC Med. 2025 Aug 26;23(1):498. doi: 10.1186/s12916-025-04336-z.
2
Fecal Microbiota Transplantation as a Salvage Therapy for Concomitant Resistant Digestive Graft Versus Host Disease and Cryptosporidiosis in a Patient Post Hematopoietic Stem Cell Transplant: about a Case.粪便微生物群移植作为造血干细胞移植术后患者同时发生的难治性消化性移植物抗宿主病和隐孢子虫病的挽救治疗：病例报告
Mediterr J Hematol Infect Dis. 2025 May 1;17(1):e2025035. doi: 10.4084/MJHID.2025.035. eCollection 2025.
3
Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation.异基因干细胞移植后急性移植物抗宿主病中的粪便微生物群移植
Visc Med. 2024 Mar 26;40(4):1-6. doi: 10.1159/000538303.
4
An enterococcal phage-derived enzyme suppresses graft-versus-host disease.一种源自肠球菌噬菌体的酶可抑制移植物抗宿主病。
Nature. 2024 Aug;632(8023):174-181. doi: 10.1038/s41586-024-07667-8. Epub 2024 Jul 10.
5
Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.肠道微生物群、微生物衍生代谢物与移植物抗宿主病。
Cancer Med. 2024 Feb;13(3):e6799. doi: 10.1002/cam4.6799. Epub 2024 Jan 18.
6
Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.与疾病发作前的类固醇敏感胃肠道移植物抗宿主病相比，急性类固醇难治性胃肠道移植物抗宿主病在肠道分类组成方面没有显著差异。
Transplant Cell Ther. 2024 Feb;30(2):237.e1-237.e9. doi: 10.1016/j.jtct.2023.11.006. Epub 2023 Nov 7.
7
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting.粪便微生物群移植在异基因干细胞移植环境中的作用。
Microorganisms. 2023 Aug 29;11(9):2182. doi: 10.3390/microorganisms11092182.
8
Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward.造血细胞移植和细胞治疗受者的粪便微生物移植：经验教训和未来发展方向。
Gut Microbes. 2023 Jan-Dec;15(1):2229567. doi: 10.1080/19490976.2023.2229567.
9
From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease.从支持到治疗：重新思考营养在急性移植物抗宿主病中的作用。
Front Immunol. 2023 Jun 8;14:1192084. doi: 10.3389/fimmu.2023.1192084. eCollection 2023.
10
Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML.随机双盲 II 期临床试验：粪便微生物群移植与安慰剂在异基因造血细胞移植和 AML 中的疗效比较。
J Clin Oncol. 2023 Dec 1;41(34):5306-5319. doi: 10.1200/JCO.22.02366. Epub 2023 May 26.
本文引用的文献
1
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.异基因造血干细胞移植后进行第三方粪便微生物群移植可重建微生物组多样性。
Blood Adv. 2018 Apr 10;2(7):745-753. doi: 10.1182/bloodadvances.2018017731.
2
Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.口服胶囊与结肠镜检查递送粪便微生物群移植对复发性艰难梭菌感染的影响：一项随机临床试验
JAMA. 2017 Nov 28;318(20):1985-1993. doi: 10.1001/jama.2017.17077.
3
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft--host-disease.反复进行粪便微生物群移植可减轻急性难治性胃肠道移植物抗宿主病中的腹泻，并导致粪便微生物群的持续变化。
Haematologica. 2017 May;102(5):e210-e213. doi: 10.3324/haematol.2016.154351. Epub 2017 Feb 2.
4
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.粪便过滤移植治疗艰难梭菌感染的疗效。
Gastroenterology. 2017 Mar;152(4):799-811.e7. doi: 10.1053/j.gastro.2016.11.010. Epub 2016 Nov 17.
5
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.用于复发性艰难梭菌感染的口服、冷冻粪便微生物群移植（FMT）胶囊。
BMC Med. 2016 Sep 9;14(1):134. doi: 10.1186/s12916-016-0680-9.
6
Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.粪便微生物群移植用于肠道类固醇难治性急性移植物抗宿主病患者。
Blood. 2016 Oct 20;128(16):2083-2088. doi: 10.1182/blood-2016-05-717652. Epub 2016 Jul 26.
7
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.冷冻与新鲜粪便微生物群移植治疗复发性艰难梭菌感染患者腹泻的临床缓解效果：一项随机临床试验。
JAMA. 2016 Jan 12;315(2):142-9. doi: 10.1001/jama.2015.18098.
8
Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant.艰难梭菌结肠炎患者粪菌移植后，万古霉素耐药肠球菌粪便优势丧失。
Open Forum Infect Dis. 2015 Jun 3;2(2):ofv078. doi: 10.1093/ofid/ofv078. eCollection 2015 Apr.
9
Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report.利用粪便微生物群移植成功治疗迷走神经切断术后的严重脓毒症和腹泻：一例报告
Crit Care. 2015 Feb 9;19(1):37. doi: 10.1186/s13054-015-0738-7.
10
Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.口服、胶囊化、冷冻粪菌移植治疗复发性艰难梭菌感染。
JAMA. 2014 Nov 5;312(17):1772-8. doi: 10.1001/jama.2014.13875.
Zotero 插件